Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Discover what to know about cash back and taxes to manage your finances better. Stay informed and make wise decisions.
28,655 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
The Supreme Court declined to hear Alan Dershowitz's $300 million defamation suit against CNN, ending a high-profile ...
Micron Technology presses the AI memory story, delivering strong margins and cloud demand while facing volatility and...
The Federal Law Enforcement Officers Association endorsed the Digital Asset Market Clarity Act on July 10, tying its ...
Palo Alto Networks’ stock fell after the latest earnings, as traders weighed a murky near-term outlook against the co...
ZachXBT has named Axiom in a probe over alleged insider trading by an employee. Axiom paused internal tools and says ...
The 2026 world will bring a new advertising cadence to the World Cup, introducing mid-match hydration breaks where ad...
Versant Media Group launches a CNBC-based direct-to-consumer platform for retail investors, pairing journalism with A...
A family facing a life-or-death medical flight denied by a major insurer turns to social media and billionaire Mark C...
Investors speculate on Kevin Warsh becoming Fed chair, a move that could alter rate paths, liquidity and the long-run...
The federal budget deficit projected to approach $2 trillion this fiscal year signals a turning point for U.S. borrow...
In a volatile crypto landscape, traders ask whether a $500 XRP bet made in 2026 could vault to five figures by 2030. ...